Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1992 2
1993 4
1994 11
1995 6
1996 7
1997 7
1998 18
1999 12
2000 16
2001 14
2002 33
2003 22
2004 21
2005 21
2006 17
2007 18
2008 30
2009 22
2010 23
2011 28
2012 25
2013 33
2014 27
2015 33
2016 48
2017 60
2018 55
2019 71
2020 71
2021 80
2022 64
2023 80
2024 160
2025 268
2026 186

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,447 results

Results by year

Filters applied: . Clear all
Page 1
Lipoprotein(a) and cardiovascular disease.
Nordestgaard BG, Langsted A. Nordestgaard BG, et al. Lancet. 2024 Sep 28;404(10459):1255-1264. doi: 10.1016/S0140-6736(24)01308-4. Epub 2024 Sep 12. Lancet. 2024. PMID: 39278229 Review.
One in five people are at high risk for atherosclerotic cardiovascular disease and aortic valve stenosis due to high lipoprotein(a). Lipoprotein(a) concentrations are lowest in people from east Asia, Europe, and southeast Asia, intermediate in p …
One in five people are at high risk for atherosclerotic cardiovascular disease and aortic valve stenosis due to high lipoprotein …
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C, Koschinsky ML; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease. Reyes-Soffer G, et al. Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147. Epub 2021 Oct 14. Arterioscler Thromb Vasc Biol. 2022. PMID: 34647487 Free PMC article. Review.
High levels of lipoprotein(a) [Lp(a)], an apoB100-containing lipoprotein, are an independent and causal risk factor for atherosclerotic cardiovascular diseases through mechanisms associated with increased atherogenesis, inflammation, and thrombosis. ...Lp(a) remains …
High levels of lipoprotein(a) [Lp(a)], an apoB100-containing lipoprotein, are an independent and causal risk factor for athero …
The Brussels International Declaration on Lipoprotein(a) Testing and Management.
Kronenberg F, Bedlington N, Ademi Z, Geantă M, Silberzahn T, Rijken M, Kaal A, Harada-Shiba M, Chen Z, Thanassoulis G, Eliasen B, Eiselé JL, Wiegman A, Ballantyne CM, Broome E, Calabrò M, Corral P, Dol A, Donato LJ, Evans E, Funabashi S, Gouni-Berthold I, Ibarluzea IG, Johnson N, Lane J, Mora S, Nordestgaard BG, Pećin I, Kaal-Poppelaars R, Langlois MR, Ray KK, Rodenbach A, Santos RD, Stroes ESG, Tada H, Vrablík M, Winokur M, Yoshida M, Nicholls SJ, Daccord M. Kronenberg F, et al. Atherosclerosis. 2025 Jul;406:119218. doi: 10.1016/j.atherosclerosis.2025.119218. Epub 2025 May 5. Atherosclerosis. 2025. PMID: 40340180 Free article.
There is striking evidence that a high lipoprotein(a) [Lp(a)] concentration is a strong, independent, and causal cardiovascular risk factor. ...The Brussels International Declaration on Lp(a) Testing and Management was co-created by the Lp(a) International Ta …
There is striking evidence that a high lipoprotein(a) [Lp(a)] concentration is a strong, independent, and causal cardiovascula …
Strategies for management of patients with elevated lipoprotein(a).
Ellberg CC, Bhatia HS. Ellberg CC, et al. Curr Opin Lipidol. 2024 Oct 1;35(5):234-240. doi: 10.1097/MOL.0000000000000950. Epub 2024 Aug 14. Curr Opin Lipidol. 2024. PMID: 39145610 Free PMC article. Review.
However, few patients are tested, including those with a personal or family history of cardiovascular disease (CVD). One often noted barrier to more widespread testing is uncertainty regarding what to do with an elevated Lp(a) level. ...The cornerstone of management …
However, few patients are tested, including those with a personal or family history of cardiovascular disease (CVD). One often noted …
Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank.
Patel AP, Wang (汪敏先) M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S, Khera AV. Patel AP, et al. Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):465-474. doi: 10.1161/ATVBAHA.120.315291. Epub 2020 Oct 29. Arterioscler Thromb Vasc Biol. 2021. PMID: 33115266 Free PMC article.
OBJECTIVE: Lp(a) (lipoprotein[a]) concentrations are associated with atherosclerotic cardiovascular disease (ASCVD), and new therapies that enable potent and specific reduction are in development. ...Approach and Results: Relationship of lipoprotein …
OBJECTIVE: Lp(a) (lipoprotein[a]) concentrations are associated with atherosclerotic cardiovascular disease (ASC …
Lipoprotein(a): A missing culprit in the management of athero-thrombosis?
Ferretti G, Bacchetti T, Johnston TP, Banach M, Pirro M, Sahebkar A. Ferretti G, et al. J Cell Physiol. 2018 Apr;233(4):2966-2981. doi: 10.1002/jcp.26050. Epub 2017 Jul 11. J Cell Physiol. 2018. PMID: 28608522 Review.
Lipoprotein(a) Lp(a) is a cholesterol-rich, LDL-like particle that is independently associated with an increased risk for ischemic heart disease, atherosclerosis, thrombosis, and stroke. ...
Lipoprotein(a) Lp(a) is a cholesterol-rich, LDL-like particle that is independently associated with an increased risk for isch …
Genetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk.
Volgman AS, Koschinsky ML, Mehta A, Rosenson RS. Volgman AS, et al. J Am Heart Assoc. 2024 Jun 18;13(12):e033654. doi: 10.1161/JAHA.123.033654. Epub 2024 Jun 15. J Am Heart Assoc. 2024. PMID: 38879448 Free PMC article. Review.
Elevated lipoprotein(a) is a genetically transmitted codominant trait that is an independent risk driver for cardiovascular disease. ...Herein, we discuss the genetic determinants of lipoprotein(a) levels, explore the pathophysiological mechanis …
Elevated lipoprotein(a) is a genetically transmitted codominant trait that is an independent risk driver for cardiovascular …
HEART UK consensus statement on Lipoprotein(a): A call to action.
Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee. Cegla J, et al. Atherosclerosis. 2019 Dec;291:62-70. doi: 10.1016/j.atherosclerosis.2019.10.011. Epub 2019 Oct 14. Atherosclerosis. 2019. PMID: 31704552 Free article. Review.
Lipoprotein(a), Lp(a), is a modified atherogenic low-density lipoprotein particle that contains apolipoprotein(a). ...This consensus statement by HEART UK is based on the evidence that Lp(a) is an independent cardiovascular disease (CVD) risk factor, provides …
Lipoprotein(a), Lp(a), is a modified atherogenic low-density lipoprotein particle that contains apolipoprotein(a). ...This con …
Lipoprotein(a) - From Biomarker to Therapy: A Review for the Clinician.
Jha M, McCarthy IR, Gelfand EV. Jha M, et al. Am J Cardiol. 2025 Jun 15;245:42-53. doi: 10.1016/j.amjcard.2025.02.034. Epub 2025 Mar 6. Am J Cardiol. 2025. PMID: 40057218 Review.
Cardiovascular disease (CVD) remains the predominant cause of morbidity and mortality globally. Amid rising CVD rates, Lipoprotein(a) [Lp(a)] has been recognized as a critical biomarker identifying individuals at an increased risk of atherosclerotic cardiovas …
Cardiovascular disease (CVD) remains the predominant cause of morbidity and mortality globally. Amid rising CVD rates, Lipoprotein …
Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies.
Alhomoud IS, Talasaz A, Mehta A, Kelly MS, Sisson EM, Bucheit JD, Brown R, Dixon DL. Alhomoud IS, et al. Pharmacotherapy. 2023 Oct;43(10):1051-1063. doi: 10.1002/phar.2851. Epub 2023 Jul 26. Pharmacotherapy. 2023. PMID: 37464942 Review.
Lipoprotein(a), or Lp(a), is structurally like low-density lipoprotein (LDL) but differs in that it contains glycoprotein apolipoprotein(a) [apo(a)]. ...Recommendations for when to screen and how to manage individuals with elevated Lp(a) vary widely between n …
Lipoprotein(a), or Lp(a), is structurally like low-density lipoprotein (LDL) but differs in that it contains glycoprotein apol …
1,447 results